Patents by Inventor Steven Ludmerer

Steven Ludmerer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hcv rna dependent rna polymerase
    Publication number: 20070149761
    Abstract: The present invention features NS5B polypeptides from different clinically important HCV genotypes. The polypeptides can be used individually, or as part of a panel of RNA-dependent RNA polymerases, to evaluate the effectiveness of a compound to inhibit NS5B activity.
    Type: Application
    Filed: January 6, 2005
    Publication date: June 28, 2007
    Inventors: Donald Graham, Amy Simcoe, Steven Ludmerer, Osvaldo Flores, Robert LaFemina
  • HCV NS3 protease inhibitors
    Publication number: 20070027071
    Abstract: The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
    Type: Application
    Filed: July 12, 2006
    Publication date: February 1, 2007
    Inventors: M. Holloway, Nigel Liverton, Steven Ludmerer, John McCauley, David Olsen, Michael Rudd, Joseph Vacca, Charles McIntyre
  • Synthetic virus-like particles with heterologous epitopes
    Publication number: 20050058988
    Abstract: The invention is a series of synthetic virus-like particles comprising a heterologous conformational epitope useful in the characterization of human papillomavirus infection, and useful to vaccinate individual for protection against HPV 6 and HPV 11 infections, and assays employing the synthetic virus-like particles.
    Type: Application
    Filed: December 16, 2003
    Publication date: March 17, 2005
    Inventors: Kathrin Jansen, Jessica Ling, Steven Ludmerer, William McClements, Xin-Min Wang
  • Synthetic HPV 16 virus-like particles
    Patent number: 5952216
    Abstract: A series of synthetic virus-like particles useful in the characterization of human papillomavirus type 16 (HPV16) infection and assays employing the synthetic particles are provided.
    Type: Grant
    Filed: December 9, 1997
    Date of Patent: September 14, 1999
    Assignee: Merck & Co., Inc.
    Inventor: Steven Ludmerer
  • Synthetic HPV16 virus-like particles
    Patent number: 5922588
    Abstract: The invention is a series of synthetic virus-like particles useful in the characterization of human papillomavirus infection and assays employing the synthetic virus-like particles.
    Type: Grant
    Filed: October 3, 1997
    Date of Patent: July 13, 1999
    Assignee: Merck & Co., Inc.
    Inventor: Steven Ludmerer
  • Synthetic HPV11 virus-like particles
    Patent number: 5795754
    Abstract: The present invention is a series of synthetic virus-like particles useful in the characterization of human papillomavirus infection and assays employing the synthetic virus-like particles.
    Type: Grant
    Filed: July 19, 1996
    Date of Patent: August 18, 1998
    Assignee: Merck & Co., Inc.
    Inventors: Steven Ludmerer, Gregory F. Hollis, Diana Benincasa, George E. Mark, III
  • Synthetic HPV11 virus-like particles
    Patent number: 5738853
    Abstract: The present invention is a series of synthetic virus-like particles useful in the characterization of human papillomavirus infection and assays employing the synthetic virus-like particles. The synthetic virus-like particles are generated from constructs designated as HPV6:4; HPV6:5; HPV6:2; HPV6:4.DELTA.132; and HPV6:4,S131G.
    Type: Grant
    Filed: October 24, 1996
    Date of Patent: April 14, 1998
    Assignee: Merck & Co., Inc.
    Inventors: Steven Ludmerer, George E. Mark, III, Diana Benincasa